Immunotherapy combo

Ovarian, bowel and non-Hodgkin’s lymphoma treatments approved for NHS use in Scotland Three new treatment options will be made available for patients in Scotland living with advanced ovarian cancer, bowel cancer and a rare form of non-Hodgkin’s lymphoma. The latest batch of drug decisions from The Scottish Medicines Consortium (SMC) includes the approval of olaparib,
0 Comments